Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression

World Journal of Gastroenterology

Volumn , Issue 29, 2014, Pages 10082-10093

  Zhang, Qing Yu ^a   Li, Ran ^a   Zeng, Guo Fang ^a   Liu, Bin ^a   Liu, Jie ^a   Shu, Yang ^a   Liu, Zhong Kao ^a   Qiu, Zhi Dong ^a   Wang, Dong Jun ^a,b   Miao, Hui Lai ^a   Li, Ming Yi ^a   Zhu, Run Zhi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Dihydromyricetin; Hepatic cancer; Invasion; Matrix metalloproteinase 9; Migration

Indexed keywords

DIHYDROMYRICETIN; FLAVONOID; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C DELTA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; FLAVONOL DERIVATIVE; MATRIX METALLOPROTEINASE INHIBITOR; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PRKCD PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ADHESION ASSAY; CELL INVASION ASSAY; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; MTT ASSAY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TUMOR INVASION; WESTERN BLOTTING; WOUND HEALING; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL INVASION; CELL VIABILITY ASSAY; DOWN REGULATION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN CELL CULTURE; PROTEIN ANALYSIS; CELL ADHESION; CELL MOTION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLAVONOLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84905851531     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i29.10082     Document Type: Article

References (46)

1. Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol 2012; 13: 218-228 [PMID: 21466422]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
3. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236 [PMID: 21685461 DOI: 10.3322/caac.20121]
4. Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 2012; 24: 277-283 [PMID: 22209238 DOI: 10.1016/j.ceb.2011.12.004]
5. Sung HJ, Kim Y, Kang H, Sull JW, Kim YS, Jang SW, Ko J. Inhibitory effect of Trolox on the migration and invasion of human lung and cervical cancer cells. Int J Mol Med 2012; 29: 245-251 [PMID: 22075980 DOI: 10.3892/ijmm.2011.832]
6. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol 2003; 170: 6244-6249 [PMID: 12794156]
7. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011; 278: 16-27 [PMID: 21087457 DOI: 10.1111/j.1742-4658.2010.07919.x]
8. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011; 9: 50-63 [PMID: 21726833]
9. Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY, Yu CC, Chung JG. Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem 2011; 59: 9032-9038 [PMID: 21770460 DOI: 10.1021/jf202027n]
10. Chen Y, Lu N, Ling Y, Wang L, You Q, Li Z, Guo Q. LYG-202, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo. J Pharmacol Sci 2010; 112: 37-45 [PMID: 20093787]
11. Ni F, Gong Y, Li L, Abdolmaleky HM, Zhou JR. Flavonoid ampelopsin inhibits the growth and metastasis of prostate cancer in vitro and in mice. PLoS One 2012; 7: e38802 [PMID: 22693649 DOI: 10.1371/journal.pone.0038802]
12. Murakami T, Miyakoshi M, Araho D, Mizutani K, Kambara T, Ikeda T, Chou WH, Inukai M, Takenaka A, Igarashi K. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors 2004; 21: 175-178 [PMID: 15630194]
13. Shen Y, Lindemeyer AK, Gonzalez C, Shao XM, Spigelman I, Olsen RW, Liang J. Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci 2012; 32: 390-401 [PMID: 22219299 DOI: 10.1523/JNEUROSCI.4639-11.2012]
14. He G, Du F, Yang W, Pei G, Zhu Y. [Effects of tengcha flavonoids on scavenging oxygen free radicals and inhibiting lipid-peroxidation]. Zhongyaocai 2003; 26: 338-340 [PMID: 14535015]
15. He GX, Yang WL, Pei G, Zhu YH, Du FL. [Studies on the effect of dihydromyricetin on antilipid-peroxidation]. Zhongguo Zhongyao Zazhi 2003; 28: 1188-1190 [PMID: 15617509]
16. Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L, Yin Z. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol 2012; 12: 278-287 [PMID: 22193240 DOI: 10.1016/j.intimp.2011.12.001]
17. Zhong ZX, Qin JP, Zhou GF, Chen XF. [Experimental studies of hypoglycemic action on total flavone of Ampelopsis grossedentata from Guangxi]. Zhongguo Zhongyao Zazhi 2002; 27: 687-689 [PMID: 12776572]
18. Zeng S, Liu D, Ye Y, Wang L, Wang W. [Anti-tumor effects of ampelopsin on human lung cancer GLC-82 implanted in nude mice]. Zhongyaocai 2004; 27: 842-845 [PMID: 15810594]
19. Zhang B, Dong S, Cen X, Wang X, Liu X, Zhang H, Zhao X, Wu Y. Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft models. Anticancer Drugs 2012; 23: 590-596 [PMID: 22241170 DOI: 10.1097/CAD.0b013e32835019f9]
20. Ye J, Zheng Y, Liu D. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells]. Zhongguo Zhongyao Zazhi 2009; 34: 761-765 [PMID: 19624024]
21. Luo GQ, Zeng S, Liu DY. [Inhibitory effects of ampelopsin on angiogenesis]. Zhongyaocai 2006; 29: 146-150 [PMID: 16617784]
22. Gao Q, Yang X, Ou M. [Effect of serum containing tengcha total flavonoid and dihydromyricetin on proliferation and apoptosis of HepG2 cells]. Zhongguo Zhongyao Zazhi 2011; 36: 500-503 [PMID: 21598552]
23. Caraballo-Miralles V, Cardona-Rossinyol A, Garcera A, Villalonga P, Soler RM, Olmos G, Lladó J. SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA. Mol Cell Neurosci 2012; 49: 282-289 [PMID: 22197680 DOI: 10.1016/j.mcn.2011.12.003]
24. Doi Y, Yashiro M, Yamada N, Amano R, Noda S, Hirakawa K. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Ann Surg Oncol 2012; 19: 2733-2743 [PMID: 22207048 DOI: 10.1245/s10434-011-2181-6]
25. Kang H, Jang SW, Ko J. Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9. J Biol Chem 2011; 286: 42072-42081 [PMID: 22009750 DOI: 10.1074/jbc.M111.272302]
26. Maegdefrau U, Bosserhoff AK. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp Mol Pathol 2012; 92: 74-81 [PMID: 22024355 DOI: 10.1016/j.yexmp.2011.10.004]
27. Wu S, Liu B, Zhang Q, Liu J, Zhou W, Wang C, Li M, Bao S, Zhu R. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells. PLoS One 2013; 8: e76886 [PMID: 24223706 DOI: 10.1371/journal.pone.0076886]
28. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006; 26: 3579-3583 [PMID: 17094486]
29. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576 [PMID: 17570226 DOI: 10.1053/j.gastro.2007.04.061]
30. Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q, Yue W, Pei XT. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology 2011; 54: 1808-1818 [PMID: 22045676 DOI: 10.1002/hep.24562]
31. Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res 2011; 13: 242-250 [PMID: 21409686 DOI: 10.1080/10286020.2010.551641]
32. Zhou J, Zeng P, Tu HH, Wang FQ. Development and application of high-performance liquid chromatography for the study of ampelopsin pharmacokinetics in rat plasma using cloud-point extraction. J Sep Sci 2011; 34: 160-168 [PMID: 21246721]
33. Liu DY, Zheng HQ, Luo GQ. [Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro]. Zhongguo Zhongyao Zazhi 2003; 28: 957-961 [PMID: 15620188]
34. Nyberg P, Heikkilä P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman UH, Pihlajaniemi T, Salo T. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 2003; 278: 22404-22411 [PMID: 12690120 DOI: 10.1074/jbc.M210325200]
35. Purcell WT, Rudek MA, Hidalgo M. Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol Oncol Clin North Am 2002; 16: 1189-1227 [PMID: 12512389]
36. Zhang M, Altuwaijri S, Yeh S. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene 2004; 23: 3080-3088 [PMID: 15048090 DOI: 10.1038/sj.onc.1207435]
37. Zhou X, Yang J, Wang Y, Li W, Li-Ling J, Deng Y, Zhang M. Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways. Hepatol Res 2012; 42: 401-411 [PMID: 22151918 DOI: 10.1111/j.1872-034X.2011.00933.x]
38. Hwang YP, Yun HJ, Kim HG, Han EH, Lee GW, Jeong HG. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms. Biochem Pharmacol 2010; 79: 1714-1726 [PMID: 20152819 DOI: 10.1016/j.bcp.2010.02.003]
39. Reunanen N, Westermarck J, Häkkinen L, Holmström TH, Elo I, Eriksson JE, Kähäri VM. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 1998; 273: 5137-5145 [PMID: 9478967]
40. Kuppers DA, Lan K, Knight JS, Robertson ES. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. J Virol 2005; 79: 9714-9724 [PMID: 16014933 DOI: 10.1128/JVI.79.15.9714-9724.2005]
41. Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2. Urology 2005; 65: 1029-1034 [PMID: 15882758 DOI: 10.1016/j.urology.2004.12.032]
42. Hsieh HL, Wu CY, Yang CM. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Glia 2008; 56: 619-632 [PMID: 18240315]
43. Smallwood ND, Hausman BS, Wang X, Liedtke CM. Involvement of NH2 terminus of PKC-delta in binding to F-actin during activation of Calu-3 airway epithelial NKCC1. Am J Physiol Cell Physiol 2005; 288: C906-C912 [PMID: 15590896 DOI: 10.1152/ajpcell.00484.2004]
44. Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase- 9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 2006; 79: 214-222 [PMID: 16275891 DOI: 10.1189/jlb.0605353]
45. Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M, Laviolette M. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol 2009; 85: 656-663 [PMID: 19164129 DOI: 10.1189/jlb.0808492]
46. Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 2009; 30: 1225-1233 [PMID: 19420016 DOI: 10.1093/carcin/bgp111]